Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PSTV
PSTV
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PSTV News
Plus Therapeutics Appoints New VP of Value Strategy
5d ago
Newsfilter
Plus Appoints New Chief Development Officer and Receives FDA Approval
Apr 10 2026
stocktwits
Plus Therapeutics Appoints New Chief Development Officer
Apr 09 2026
Newsfilter
Plus Therapeutics Receives FDA Orphan Drug Designation
Apr 08 2026
Newsfilter
Plus Therapeutics Secures New CPT Code for CNSide Test
Apr 07 2026
Newsfilter
Plus Therapeutics Secures New Payer Agreement with Highmark
Apr 02 2026
Newsfilter
Plus Therapeutics Grants Inducement Awards to New Employees
Mar 31 2026
Newsfilter
Plus Therapeutics Announces 1-for-25 Reverse Stock Split
Mar 31 2026
seekingalpha
Plus Therapeutics Approves 1-for-25 Reverse Stock Split
Mar 31 2026
Newsfilter
Plus Therapeutics Appoints Ron Andrews to Board
Mar 26 2026
Newsfilter
Plus Therapeutics Study Shows Early Detection Can Reduce Healthcare Costs
Mar 19 2026
Globenewswire
Plus Therapeutics Releases 2026 Milestones and Financial Results
Mar 12 2026
seekingalpha
Plus Therapeutics Receives AMA Approval for New CPT Code
Feb 25 2026
Newsfilter
Plus Therapeutics (PSTV) Outlines 2026 Goals to Advance REYOBIQ and Expand CNSide Platform
Jan 22 2026
NASDAQ.COM
Plus Therapeutics (PSTV) Provides Business Update with $16.6 Million Cash Position
Jan 22 2026
NASDAQ.COM
Plus Therapeutics (PSTV) to Provide Business Update on January 22, 2026
Jan 21 2026
Newsfilter
Show More News
